Current perspectives of autologous stem cell transplantation for severe juvenile idiopathic arthritis

References

• Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31(2)390–392
   PubMed Web of Science ®Google Scholar
• Grom AA. Natural killer cell dysfunction: A common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis?. Arthritis Rheum 2004; 50(3)689–698
   PubMedGoogle Scholar
• Ramanan AV, Schneider R. Macrophage activation syndrome – What's in a name!. J Rheumatol 2003; 30(12)2513–2516
   PubMedGoogle Scholar
• Ravelli A, Caria MC, Buratti S, et al. Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis. J Rheumatol 2001; 28(4)865–867
   PubMed Web of Science ®Google Scholar
• Petty RE. Prognosis in children with rheumatic diseases: justification for consideration of new therapies. Rheumatology (Oxford) 1999; 38(8)739–742
   PubMedGoogle Scholar
• Wallace CA, Sherry DD. Trial of intravenous pulse cyclophosphamide and methylprednisolone in the treatment of severe systemic-onset juvenile rheumatoid arthritis. Arthritis Rheum 1997; 40(10)1852–1855
   PubMedGoogle Scholar
• Wallace CA. Current management of juvenile idiopathic arthritis. Best Pract Res Clin Rheumatol 2006; 20(2)279–300
   PubMed Web of Science ®Google Scholar
• Lovell DJ, Giannini EH, Reiff A, et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med 2000; 342(11)763–769
   PubMed Web of Science ®Google Scholar
• Quartier P, Taupin P, Bourdeaut F, et al. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum 2003; 48(4)1093–1101
   PubMed Web of Science ®Google Scholar
• Brinkman DM, de Kleer IM, ten Cate R, et al. Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: Long-term follow-up of a prospective clinical trial. Arthritis Rheum 2007; 56(7)2410–2421
   PubMed Web of Science ®Google Scholar
• De Kleer IM, Brinkman DM, Ferster A, et al. Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity. Ann Rheum Dis 2004; 63(10)1318–1326
   PubMed Web of Science ®Google Scholar
• Wulffraat N, van Royen A, Bierings M, et al. Autologous haemopoietic stem-cell transplantation in four patients with refractory juvenile chronic arthritis. Lancet 1999; 353(9152)550–553
   PubMedGoogle Scholar
• Ferreira RA, Vastert SJ, Abinun M, et al. Hemophagocytosis during fludarabine-based SCT for systemic juvenile idiopathic arthritis. Bone Marrow Transplant 2006; 38(3)249–251
   PubMedGoogle Scholar
• Nakagawa R, Kawano Y, Yoshimura E, et al. Intense immunosuppression followed by purified blood CD34+ cell autografting in a patient with refractory juvenile rheumatoid arthritis. Bone Marrow Transplant 2001; 27(3)333–336
   PubMedGoogle Scholar
• Sreedharan A, Bowyer S, Wallace CA, et al. Macrophage activation syndrome and other systemic inflammatory conditions after BMT. Bone Marrow Transplant 2006; 37(7)629–634
   PubMedGoogle Scholar
• Wedderburn LR, Abinun M, Palmer P, Foster HE. Autologous haematopoietic stem cell transplantation in juvenile idiopathic arthritis. Arch Dis Child 2003; 88(3)201–205
   PubMedGoogle Scholar
• Stephan JL, Galambrun C. Reactive hemophagocytic syndrome in children. Arch Pediatr 2000; 7(3)278–286
   PubMedGoogle Scholar
• Goransdotter Ericson K, Fadeel B, Nilsson-Ardnor S, et al. Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis. Am J Hum Genet 2001; 68(3)590–597
   PubMedGoogle Scholar
• Grom AA, Villanueva J, Lee S, et al. Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. J Pediatr 2003; 142(3)292–296
   PubMed Web of Science ®Google Scholar
• Wulffraat NM, Rijkers GT, Elst E, et al. Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation. Rheumatology (Oxford) 2003; 42(2)375–379
   PubMed Web of Science ®Google Scholar
• Giannini EH, Ruperto N, Ravelli A, et al. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997; 40(7)1202–1209
   PubMed Web of Science ®Google Scholar
• Hough RE, Snowden JA, Wulffraat NM. Haemopoietic stem cell transplantation in autoimmune diseases: A European perspective. Br J Haematol 2005; 128(4)432–459
   PubMed Web of Science ®Google Scholar
• De Kleer I, Vastert B, Klein M, et al. Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network. Blood 2006; 107(4)1696–1702
   PubMed Web of Science ®Google Scholar
• Albani S, Prakken B. T cell epitope-specific immune therapy for rheumatic diseases. Arthritis Rheum 2006; 54(1)19–25
   PubMedGoogle Scholar
• Kamphuis S, Kuis W, de Jager W, et al. Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis. Lancet 2005; 366(9479)50–56
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363(9419)1439–1441
   PubMed Web of Science ®Google Scholar
• Augello A, Tasso R, Negrini SM, et al. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum 2007; 56(4)1175–1186
   PubMed Web of Science ®Google Scholar
• Djouad F, Fritz V, Apparailly F, et al. Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum 2005; 52(5)1595–1603
   PubMed Web of Science ®Google Scholar